Related Experiment Video
Updated: Dec 14, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Pathogenesis and management of myocardial injury in coronavirus disease 2019
Zhi-Yao Wei1, Yong-Jian Geng2, Ji Huang3
1Center for Coronary Heart Disease, Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Insights
Coronavirus disease 2019 (COVID-19) poses significant cardiovascular risks, especially for older adults. This review details COVID-19
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a global pandemic.
- COVID-19 presents with high infectivity and diverse clinical symptoms.
- Cardiovascular complications, including myocardial injury, are noted in COVID-19 patients, particularly the elderly.
Purpose of the Study:
- To review the epidemiology of COVID-19.
- To explore the mechanisms behind COVID-19 cardiovascular complications.
- To summarize clinical manifestations and management strategies for these complications.
Main Methods:
- Literature review of epidemiological data.
- Analysis of studies on COVID-19 pathophysiology.
- Synthesis of clinical case reports and management guidelines.
Main Results:
- COVID-19 exhibits rapid global spread and varied clinical presentations.
- Mechanisms linking SARS-CoV-2 infection to cardiac injury are multifaceted.
- Management strategies are evolving, focusing on supportive care and addressing specific cardiovascular issues.
Conclusions:
- COVID-19 significantly impacts cardiovascular health, necessitating focused clinical attention.
- Understanding the cardiovascular implications of COVID-19 is crucial for patient outcomes.
- Further research is needed to refine treatment protocols for COVID-19-related cardiac conditions.
Abstract:
The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has become a major health crisis and a worldwide pandemic. COVID-19 is characterized by high infectivity, long incubation period, diverse clinical presentations, and strong transmission intensity. COVID-19 can cause myocardial injury as well as other cardiovascular complications, particularly in senior patients with pre-existing medical conditions. The current review summarizes the epidemiological characteristics, potential mechanisms, clinical manifestations, and recent progress in the management of COVID-19 cardiovascular complications.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Myocarditis II: Clinical Features and Diagnostic Tests

